Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Calcium|May 7, 2005
[Change in the definition of osteoporosis especially on bone quality]Hideaki Kishimoto
Archives of Osteoporosis|August 23, 2015
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAHideaki Kishimoto, Masayuki Maehara
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|April 23, 2021
The Performance of Secondary Nasal Alar Base Revision for Unilateral Cleft Lip by Single YV-Plasty (the Importance of Overcorrection During Surgery)Yoshitaka Matsuura, Hideaki Kishimoto
Bone|November 5, 2013
Efficacy, tolerability and safety of once-monthly administration of 75mg risedronate in Japanese patients with involutional osteoporosis: a comparison with a 2.5mg once-daily dosage regimenHiroshi Hagino, Hideaki Kishimoto, Hiroaki Ohishi, et al.
Plastic and Reconstructive Surgery. Global Open|October 21, 2016
The Lesser Palatine Nerve Innervates the Levator Veli Palatini MuscleHideaki Kishimoto, Yoshitaka Matsuura, Katsuya Kawai, et al.
Journal of Bone and Mineral Metabolism|December 17, 2008
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsulesTetsuo Inoue, Toshiharu Fujita, Hideaki Kishimoto, et al.
Journal of Bone and Mineral Metabolism|August 18, 2019
Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosisSatoshi Soen, Hideaki Kishimoto, Hiroshi Hagino, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 29, 2015
Three-dimensional imaging of palatal muscles in the human embryo and fetus: Development of levator veli palatini and clinical importance of the lesser palatine nerveHideaki Kishimoto, Shigehito Yamada, Toru Kanahashi, et al.
Journal of Bone and Mineral Metabolism|November 12, 2013
Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trialTetsuo Nakano, Masataka Shiraki, Toshitsugu Sugimoto, et al.
Journal of Bone and Mineral Metabolism|August 29, 2006
Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimenHideaki Kishimoto, Masao Fukunaga, Kazuhiro Kushida, et al.
Pageof 3